Swiss pharma giant Roche announced positive five-year efficacy, safety and durability data from the Phase III Portal study, a ...

US Biotech Regeneron Pharmaceuticals today announced financial results for the second quarter of 2025 and provided a business ...

US biotech major Biogen (Nasdaq: BIIB) reported a 7% rise in its second quarter revenue Friday, with sales of $2.45 billion.

US mRNA specialist Moderna has announced that the UK Court of Appeal has upheld the validity of its EP'949 patent.

For the first time in decades, the pharmaceutical industry has been directly affected by a geopolitical trade negotiation ...